CN103202881A - External agent composition for treating rash - Google Patents
External agent composition for treating rash Download PDFInfo
- Publication number
- CN103202881A CN103202881A CN2013101601097A CN201310160109A CN103202881A CN 103202881 A CN103202881 A CN 103202881A CN 2013101601097 A CN2013101601097 A CN 2013101601097A CN 201310160109 A CN201310160109 A CN 201310160109A CN 103202881 A CN103202881 A CN 103202881A
- Authority
- CN
- China
- Prior art keywords
- percent
- erythra
- composition
- preparation
- diphenhydramine
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Landscapes
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Abstract
The invention discloses an external agent composition for treating rash. The medicinal composition takes diphenhydramine, camphor, menthol, isopropyl-cresol, glycyrrhetinic acid and eucalyptus oil as effective medicinal components along with auxiliary components allowed by the external preparation, wherein the effective medicinal components comprise the following components in percentage by weight: 5-24 percent of diphenhydramine, 6-15 percent of camphor, 16-45 percent of menthol, 0.8-3.5 percent of isopropyl-cresol, 1.5-4.5 percent of gly cyrrhetinic acid and 6-20 percent of eucalyptus oil. The external agent composition can treat dermatitis, eczema, sudoral eruptions and other rash diseases and eliminate or relieve skin itching caused by biting of mosquitoes, bees, louses, bugs and other poisonous insects and has the effects of diminishing inflammation, relieving itching and killing germs. The external agent composition is readily available in raw materials and simple in preparation and has the characteristics of wide application population, high safety, obvious effect and convenience in use.
Description
Technical field
The present invention relates to a kind of preparation composition for external use with treatment skin, be specifically related to a kind of preparation composition for external use for the treatment of erythra.
Background technology
Erythra diseases such as dermatitis, eczema, miliaria are the common skin disease, belong to frequently-occurring disease and susceptible disease.At present, the main mode for the treatment of is smeared for adopting the ointment, emulsifiable paste and the disinfectant preparation that contain chemicals compositions such as hormone to carry out external, or take anti-resistance drug amine (as loratadine etc.), its effect is many to be difficult to remove the cause of disease based on antipruritic, and life-time service hormones composition, not only can produce many disadvantageous untoward reaction to health, easily make source of disease microorganisms drug resistance yet, further increased the difficulty of treatments such as disinfection, and above-mentioned therapeutic effect not too desirable.
Summary of the invention
Technical problem to be solved by this invention provides a kind of preparation composition for external use for the treatment of erythra.
The technical problem that the present invention also will solve provides the preparation method of the preparation composition for external use of above-mentioned treatment erythra.
For solving the problems of the technologies described above, the technical solution used in the present invention is as follows:
A kind of preparation composition for external use for the treatment of erythra is effective medicinal ingredient by diphenhydramine, Camphora, Mentholum, isopropyl cresol, enoxolone, Oleum Eucalypti etc., forms jointly with the adjunct ingredient that external preparation allows.The weight portion ratio of each effective medicinal ingredient is diphenhydramine 5～24%, Camphora 6～15%, Mentholum 16～45%, isopropyl cresol 0.8～3.5%, enoxolone 1.5～4.5%, Oleum Eucalypti 6～20%.
The method for preparing the preparation composition for external use of above-mentioned treatment erythra, comprise the steps: to get Mentholum, the Camphora of aforementioned proportion, after it is ground into fine powder, adds remaining composition again and fully stir well, get the adjuvant light liquid petrolatum and add in the mentioned component to 100%, constantly stirring and dissolving is to even, filter, left standstill 24 hours, get supernatant, packing, namely.
Above-mentioned preparation composition for external use is the diphenhydramine of described composition in the application for the treatment of in the erythra, has calmness, antianaphylactic effect, can eliminate various allergic symptoms, is widely used in various allergic skin diseases, as urticaria, mosquito bite etc.
Above-mentioned preparation composition for external use is the Camphora of described composition in the application for the treatment of in the erythra, has pain relieving, and antibiotic, anthelmintic action can alleviate the pain that rheumatism is brought, and also can produce refrigerant effect, thereby antiinflammatory is arranged, the effect that treatment is burnt.
Above-mentioned preparation composition for external use is the Mentholum of described composition in the application for the treatment of in the erythra, can act on pain relieving, alleviates headache especially, and migraine, antiinflammatory blood stasis removing, but also stuffy nose relieving plug, and its refrigerant fragrance can clear the head.
Above-mentioned preparation composition for external use is the isopropyl cresol of described composition in the application for the treatment of in the erythra, has the disinfecting, antimicrobial effect, but not only kill bacteria but also can kill fungus has stronger sterilizing power than phenol, often is applied to antiinflammatory, pain relieving, aspect such as antipruritic.
The application of above-mentioned preparation composition for external use in the treatment erythra, be the enoxolone of described composition, the various acute inflammation all there is inhibitory action, be used for the treatment of the infection of staphylococcus, streptococcus, escherichia coli, pylori etc. clinically, have effects such as antiinflammatory antiallergic, inhibition bacterial reproduction.
Above-mentioned preparation composition for external use is the Oleum Eucalypti of described composition in the application for the treatment of in the erythra, has special aroma, and acrid in the mouth, cold have the wind-expelling pain-stopping effect, are used for skin pruritus, neuralgia etc.
The using method of the preparation composition for external use of above-mentioned treatment erythra and consumption: external is coated with when needing and puts on the skin in the affected part, every day three to four times.
The present invention has following beneficial effect:
1, the present invention can treat erythra diseases such as dermatitis, eczema, miliaria, and eliminates or slow down the skin pruritus of biting because of poisonous insects such as mosquito, honeybee, louse, Cimex bedbugs that causes, has antiinflammatory, antipruritic and disinfection effect;
2, the present invention is the composition series products, is refrigerant Herba Menthae and Camphora abnormal smells from the patient, in adjuvant treatment of diseases, can play the prevention mosquito bite, wherein be coated with the skin coolness, can make the mood of user become happy, joyful;
3, the present invention is pure natural substance, does not contain any artificial synthetic ingredient and hormone composition, and it is extensive that product is suitable for the crowd, also can use this preparation composition for external use securely for the thinner crowd of one-year-old above keratodermatitis such as child.
The specific embodiment
Below in conjunction with specific embodiment, further set forth the present invention.Yet, those skilled in the art will readily understand that the described concrete material proportion of embodiment, process conditions and result thereof only are used for explanation the present invention, and should also can not limit the present invention described in detail in claims.
Embodiment 1:
A kind of preparation composition for external use for the treatment of erythra is effective medicinal ingredient by diphenhydramine, Camphora, Mentholum, isopropyl cresol, enoxolone, Oleum Eucalypti etc., forms jointly with the adjunct ingredient that external preparation allows.The weight portion ratio of each effective medicinal ingredient is diphenhydramine 13%, Camphora 6.5%, Mentholum 32%, isopropyl cresol 1.2%, enoxolone 2.4%, Oleum Eucalypti 12%.
The method for preparing the preparation composition for external use of above-mentioned treatment erythra, comprise the steps: to get Mentholum, the Camphora of aforementioned proportion, after it is ground into fine powder, adds remaining composition again and fully stir well, get the adjuvant light liquid petrolatum and add in the mentioned component to 100%, constantly stirring and dissolving is to even, filter, left standstill 24 hours, get supernatant, packing, namely.
Embodiment 2:
A kind of preparation composition for external use for the treatment of erythra is effective medicinal ingredient by diphenhydramine, Camphora, Mentholum, isopropyl cresol, enoxolone, Oleum Eucalypti etc., forms jointly with the adjunct ingredient that external preparation allows.The weight portion ratio of each effective medicinal ingredient is diphenhydramine 12%, Camphora 8%, Mentholum 30%, isopropyl cresol 2.5%, enoxolone 3.5%, Oleum Eucalypti 15%.
The method for preparing the preparation composition for external use of above-mentioned treatment erythra, comprise the steps: to get Mentholum, the Camphora of aforementioned proportion, after it is ground into fine powder, adds remaining composition again and fully stir well, get the adjuvant light liquid petrolatum and add in the mentioned component to 100%, constantly stirring and dissolving is to even, filter, left standstill 24 hours, get supernatant, packing, namely.
Embodiment 3:
A kind of preparation composition for external use for the treatment of erythra is effective medicinal ingredient by diphenhydramine, Camphora, Mentholum, isopropyl cresol, enoxolone, Oleum Eucalypti etc., forms jointly with the adjunct ingredient that external preparation allows.The weight portion ratio of each effective medicinal ingredient is diphenhydramine 16%, Camphora 8%, Mentholum 40%, isopropyl cresol 1%, enoxolone 2%, Oleum Eucalypti 6%.
The method for preparing the preparation composition for external use of above-mentioned treatment erythra, comprise the steps: to get Mentholum, the Camphora of aforementioned proportion, after it is ground into fine powder, adds remaining composition again and fully stir well, get the adjuvant light liquid petrolatum and add in the mentioned component to 100%, constantly stirring and dissolving is to even, filter, left standstill 24 hours, get supernatant, packing, namely.
In the various embodiments described above, can be according to the usual manner of external preparation, select with different adjunct ingredients with or preparation method, can obtain multiple operational appropriate format preparations such as corresponding ointment, liniment, varnish, tincture, spraying tincture respectively.
Claims (2)
1. preparation composition for external use for the treatment of erythra, it is characterized in that: this pharmaceutical composition is effective medicinal ingredient by diphenhydramine, Camphora, Mentholum, isopropyl cresol, enoxolone, Oleum Eucalypti etc., forms jointly with the adjunct ingredient that external preparation allows; The weight portion ratio of each effective medicinal ingredient is diphenhydramine 5～24%, Camphora 6～15%, Mentholum 16～45%, isopropyl cresol 0.8～3.5%, enoxolone 1.5～4.5%, Oleum Eucalypti 6～20%.
2. a kind of preparation composition for external use for the treatment of erythra according to claim 1 and 2, it is characterized in that: described preparation composition for external use can be treated erythra diseases such as dermatitis, eczema, miliaria, and eliminate or slow down the skin pruritus of biting because of poisonous insects such as mosquito, honeybee, louse, Cimex bedbugs that causes, have antiinflammatory, antipruritic and disinfection effect.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN2013101601097A CN103202881A (en) | 2013-05-03 | 2013-05-03 | External agent composition for treating rash |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN2013101601097A CN103202881A (en) | 2013-05-03 | 2013-05-03 | External agent composition for treating rash |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CN103202881A true CN103202881A (en) | 2013-07-17 |
Family
ID=48750435
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN2013101601097A Pending CN103202881A (en) | 2013-05-03 | 2013-05-03 | External agent composition for treating rash |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN103202881A (en) |
Cited By (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN104906109A (en) * | 2015-04-30 | 2015-09-16 | 柳州立洁科技有限公司 | Infantile eczema cream |
| CN108567619A (en) * | 2017-08-27 | 2018-09-25 | 无锡市科姆斯化工科技有限公司 | A kind of self-control anti-inflammatory fash body film |
| CN112294826A (en) * | 2020-12-03 | 2021-02-02 | 滁州向日葵药业有限公司 | Traditional Chinese medicine composition for inhibiting helicobacter pylori and application thereof |
Citations (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1615889A (en) * | 2003-11-14 | 2005-05-18 | 李中变 | Medicine for treating skin disease |
| CN1647803A (en) * | 2004-01-20 | 2005-08-03 | 北京东方凯恩医药科技有限公司 | Chinese medicine composition plaster for external anti-inflammation and analgetics |
-
2013
- 2013-05-03 CN CN2013101601097A patent/CN103202881A/en active Pending
Patent Citations (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1615889A (en) * | 2003-11-14 | 2005-05-18 | 李中变 | Medicine for treating skin disease |
| CN1647803A (en) * | 2004-01-20 | 2005-08-03 | 北京东方凯恩医药科技有限公司 | Chinese medicine composition plaster for external anti-inflammation and analgetics |
Non-Patent Citations (2)
| Title |
|---|
| QUEENSLAI: "[孕妇用药]能用强力无比膏吗？", 《HTTP://WWW.GZMAMA.COM/THREAD-2664677-1-1.HTML》, 17 September 2011 (2011-09-17) * |
| 佚名: "无比膏VS无比滴，消肿止痒谁更强？", 《HTTP://GOODS.PCBABY.COM.CN/GA/JDCP/1106/1011298.HTML》, 30 June 2011 (2011-06-30) * |
Cited By (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN104906109A (en) * | 2015-04-30 | 2015-09-16 | 柳州立洁科技有限公司 | Infantile eczema cream |
| CN108567619A (en) * | 2017-08-27 | 2018-09-25 | 无锡市科姆斯化工科技有限公司 | A kind of self-control anti-inflammatory fash body film |
| CN112294826A (en) * | 2020-12-03 | 2021-02-02 | 滁州向日葵药业有限公司 | Traditional Chinese medicine composition for inhibiting helicobacter pylori and application thereof |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US20150264935A1 (en) | Semi-Fluidic Composition for Lubricating, Moisture Retaining, Disinfecting, Sterilizing and Method Using the Same | |
| WO2017101790A1 (en) | Pharmaceutical composition for treating cutaneous pruritus and use thereof | |
| US20070098671A1 (en) | Composition and method of treatment for irritated skin | |
| Sienkiewicz et al. | Recent patents regarding essential oils and the significance of their constituents in human health and treatment | |
| CN112915055A (en) | Multi-effect mite-killing-relieving composition and application thereof | |
| WO2008104076A1 (en) | Electrocolloidal silver and echinacea root antimicrobial formulation | |
| CN109432201B (en) | Gynecological antibacterial gel and preparation method thereof | |
| CN101474284B (en) | External use medicament for treating fungal dermatopathy | |
| CN103202881A (en) | External agent composition for treating rash | |
| CN104922248A (en) | Antibacterial and anti-inflammatory Chinese herbal compound gel and preparation method thereof | |
| EP2611453B1 (en) | Antifungal composition | |
| CN103223015A (en) | Muscle soreness and skin itch treatment drug composition and preparation method thereof | |
| CN106176603A (en) | A kind of plants essential oil micro emulsion gel and its preparation method and application | |
| CN106267329A (en) | A kind of plants essential oil gel dressing and its preparation method and application | |
| CN109464621A (en) | A kind of external preparation and preparation method thereof for treating eczema | |
| KR102251911B1 (en) | Silver ion bacteriostatic hand sanitizer and preparation method and application thereof | |
| CN108079050A (en) | Herbal skin bacteria inhibiting composition and preparation method and application | |
| CN101336966B (en) | Osmidrosis dispelling liniment containing natural essential oil of Zingiber corallinum Hance | |
| US20170027881A1 (en) | Composition and related methods for treatment of pilosebaceous diseases | |
| CN104000767B (en) | A kind of Feminine care solution and preparation method thereof | |
| KR20040087380A (en) | Essential oil composition with excellent antibacterial effect on oral bacteria | |
| KR101326679B1 (en) | Skin external composition for treating or alleviating diaper rash containing zinc oxide stabilized by polyglyceryl-2 dipolyhydroxystearate | |
| WO2008035370A2 (en) | Compositions for prevention and treatment of mastitis and metritis | |
| KR20190045050A (en) | Food composition for treating cold and flu | |
| CN101375837B (en) | Medicament composition for treating dermatopathy as well as preparation method and use thereof |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| C10 | Entry into substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| C02 | Deemed withdrawal of patent application after publication (patent law 2001) | ||
| WD01 | Invention patent application deemed withdrawn after publication |
Application publication date: 20130717 |